• Critics continue to raise doubts about the conclusions of the Term Breech Trial.
Introduction
The mode of delivery of the term breech is one of the few big questions in obstetrics that has been subject to the force majeure of the international obstetric community and to a major international randomised controlled trial with sufficient power to attempt to answer it. The 2000 Term Breech Trial (TBT) 1 demonstrated that planned caesarean section was safer: even its interim findings caused its data monitoring committee to terminate the trial prematurely because the results obtained had answered the research question before the proposed end of recruitment.
Why, then, in the wake of such seemingly convincing data, has the controversy raged on? There are continued criticisms of the Term Breech Trial and some authors have even called for the withdrawal of its recommendations. In this article we review the published data for and against vaginal breech delivery.
For vaginal breech delivery
See Table 1 . Carefully selected populations of breech presentation at term have been reviewed to demonstrate that the results from planned vaginal breech delivery are comparable to planned caesarean section. The largest of these studies was by the PREMODA study group.
2 Published in 2006, this was a prospective study of just over 8000 women in maternity units in France and Belgium comparing vaginal delivery with elective caesarean section. The authors state that in France at the time of the study (2001-02), vaginal delivery of breech presentation was 'standard practice' and routinely offered to women who conformed to strict selection criteria required by the Collège National des Gynécologues et Obstétriciens Français (CNGOF) guidelines (Box 1). Of the women who planned a vaginal delivery, 71% were successful and, apart from a 5-minute Apgar score Ͻ4, none of the severe adverse individual outcomes differed between the two groups. There was only one neonatal death of a nonmalformed infant and it was in the caesarean group. The authors comment on critical management differences between their population and those included in the Term Breech Trial. For example, the use of pelvimetry (82.4% in PREMODA versus 9.8% in the Term Breech Trial), fetal heart rate monitoring (100% versus 33.4%) and length of second stage Ͼ60 minutes (0.2% versus 5.0%). They acknowledge that there may be a slightly greater neonatal risk with vaginal delivery but that it is not as great as that concluded by the authors of the Term Breech Trial. Their improved outcome is attributed to their strict selection criteria and management guidelines, which aim to minimise this risk.
Other authors have also published studies showing comparable outcomes in smaller populations. Irion et al. 3 in Switzerland compared 385 planned vaginal deliveries with 320 elective caesareans and found fewer maternal complications in the vaginal group and no difference in corrected neonatal morbidity.
In Dublin, Alarab et al. 4 published data on 641 deliveries (343 elective caesarean deliveries and 298 trials of vaginal delivery, of which 146 were successful), again using strict selection criteria for allowing a trial of vaginal delivery. They reported only 2 neonates born vaginally with Apgar scores of 7 at 5 minutes (both were neurologically normal at 6 weeks) and no non-anomalous perinatal deaths, 6 This showed that the prevalence of death or abnormal neurodevelopment at 2 years did not differ between the vaginal and caesarean groups.
Hence, the published data does come from smaller populations than the Term Breech Trial but predominantly from developed countries where prelabour screening and counselling is, undoubtedly, more robust. Using these stringent selection criteria, authors have reported improved maternal outcomes and, in most studies, comparable neonatal outcomes. In some instances, a slightly poorer immediate neonatal outcome is reported, as measured by Apgar scores, but long-term data on these cases, although limited, appears to be reassuring.
Against vaginal breech delivery
See Table 2 . The case for planned elective caesarean section for breech presentation at term has been powerfully reviewed by Burke 7 and is advocated in the RCOG Green-top Guideline 8 and the American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice.
9
The Term Breech Trial is the only randomised controlled trial available to compare the safety of planned caesarean section with planned vaginal delivery for term frank and complete singleton breech presentations. Two thousand and eightyeight women were recruited from 121 centres in 26 countries. Its conclusions, which halted the trial prematurely in 1999 (because it would have been unethical to continue), were that the combined outcome of perinatal and neonatal death and serious neonatal morbidity, excluding lethal congenital anomalies, was significantly lower in the planned caesarean section group than in the planned vaginal delivery group (1.6% versus 5.0%, relative risk [RR] 0.33) and that there were no statistically significant differences between the groups in terms of maternal mortality or serious morbidity.
Further subanalyses of the Term Breech Trial showed that, after a further series of exclusions (deliveries after prolonged labour, labours induced or augmented with oxytocin or prostaglandins, cases with an uncertain or footling presentation at delivery, or cases where there was no skilled or experienced clinician present at the birth), the combined outcomes for perinatal mortality, neonatal mortality or serious neonatal morbidity with planned caesarean section, rather than planned vaginal breech delivery, was 16/1006 (1.6%) compared with 23/704 (3.35%) (RR 0.49; CI 0.26-0.91; Pϭ0.02). If the results are further subdivided into those obtained in countries with low perinatal mortality (Ͻ20/1000) and those with higher perinatal mortality (Ͼ20/1000) the results show that the benefits of planned caesarean section were even more significant in countries with lower perinatal mortality.
Subsequent to the publication of the Term Breech Trial, there have been a number of published accounts of the effect of planned elective caesarean section for term breech presentation on whole populations. A review of the Dutch perinatal database showed that the rate of planned elective caesarean section for term breech changed from 49% in the 33 months prior to the publication of the Term Breech Trial to 80% in the 25 months afterwards. 10 The analysis included more than 33 000 infants. This change led to a halving of the perinatal mortality rates and rates of low Apgar scores, as well as the rates of birth trauma, which fell by three-quarters. The authors suggest that this equates to more than 60 Dutch children who are alive today who might not have been prior to the Term Breech Trial. Published rates of neonatal mortality are even lower in data from California, where the planned caesarean section rates were even higher, at 95%, in a population of more than 100 000 term breeches.
11 They found that the risk of neonatal mortality in planned caesarean section compared with vaginal breech delivery was substantially decreased (odds ratio [OR] 9.2). In this study even the highly selected 5% of multiparae who delivered vaginally had higher rates of neonatal trauma and asphyxia but not neonatal death. These findings are replicated in other population-based studies from Denmark and Sweden including some 50 000 women. 12, 13 In 2005, the Swedish Collaborative Breech Group published findings of a national cohort study 12 of more than 22 000 breech deliveries. They found that perinatal or infant mortality at planned vaginal breech delivery was significantly higher than at planned caesarean section (OR 3 • Fetal weight estimated between 2500-3800 g (with clinical and ultrasound examinations)
• Frank breech
• Continuous electronic fetal heart rate monitoring for fetal surveillance during labour
• Informed consent from the woman authors further estimate that 400 caesarean sections would need to be performed to prevent the death of one baby. The Danish Medical Birth Registry 13 reviewed 15 441 primiparous women who delivered a singleton infant as a breech between 1982-95 and found that 48.6% delivered by elective caesarean section, 15.3% vaginally and 36.1% by emergency caesarean section. Their findings of reduced rates of intrapartum and neonatal death in infants further corroborate the contention that prelabour planned caesarean section is the safest option for the neonate.
There have been four large retrospective population based datasets, published since the publication of the Term Breech Trial, comprising more than 170 000 breech deliveries. All have concluded that elective caesarean section is safer for term breech babies and that it leads to lower rates of neonatal morbidity and mortality.
A further systematic review of three trials with 2396 participants (Hofmeyr and Hannah, 2003) 14 showed that caesarean delivery occurred in 1060/1169 (91%) of those allocated to caesarean section and 550/1227 (45%) of those allocated to vaginal delivery. Perinatal or neonatal death (excluding fatal anomalies) or short-term neonatal morbidity was reduced with a policy of planned caesarean section (RR 0.33; 95% CI 0.19-0.56).
The Term Breech Trial has also been subject to an economic evaluation, 15 which has demonstrated that the costs were lower in the group allocated to planned caesarean section than in the group allocated to vaginal delivery ($7165 versus $8042 [Canadian $]). These costs are primarily related to the hospital and physician costs for vaginal breech delivery, as well as the higher cost of epidural anaesthesia and the costs of neonatal intermediate and intensive care for women and babies allocated to vaginal breech delivery.
Discussion
There has been continued criticism of the Term Breech Trial from around the world. These criticisms have included allegations that:
• the standard of care was not consistent, including poor antepartum and intrapartum fetal assessment • the inclusion criteria were not adhered to • a large number of women were recruited in labour.
16-18
Many of these criticisms are based upon a fundamental misunderstanding of the principles of randomised controlled trials or have been effectively rebutted by a series of secondary analyses by the original authors of the Term Breech Trial. 19 Claims have been made that many women who delivered vaginally were not attended by an obstetrician, whereas only one woman delivered by planned elective caesarean section was not attended by an obstetrician. No matter that the women were delivered by practitioners who considered themselves to be, and were certified by their head of institution as being, competent and experienced at vaginal breech delivery. The multicentre randomised controlled trial is designed to produce generalisable results that are useful to all practitioners, rather than results from one practitioner or a small group of practitioners or a single group or grade of practitioners, which tell us more about their skills than the inherent risks of delivery.
The subsequent publication of four large European population studies all showing an improved neonatal outcome after elective caesarean support the Term Breech Trial findings, so these criticisms may have been justified but cannot detract from the overall conclusions of the study.
So what about the increased number of caesarean sections we are to perform and the future implications for mother and baby? Recent data from the 1997-1999 Confidential Enquiry into Maternal and Child Health 20 confirm the relative safety of elective caesarean section: one maternal death in 78 000 elective caesarean sections was reported. A previous analysis by Hall 21 described rates of death per million maternities of 20.6 following vaginal delivery, compared with 58.5 after elective caesarean section and 182.0 following emergency caesarean section. The Danish study 13 of over 15 000 primiparous women with breech presentation at term described rates of maternal mortality and morbidity as well as long-term follow-up data on urinary and anal problems, fecundity and obstetric complications in subsequent pregnancies. The majority of maternal deaths in this series were unrelated to pregnancy and the incidence of haemorrhage and anaemia did not differ in the two groups. Emergency caesarean section increased the risk of pelvic infection and puerperal fever. In the long term, vaginal delivery increased the risk of urinary incontinence between 3-6 times but the rate of continence procedures was equal in all groups. Elective caesarean section was not associated with subsequent ectopic pregnancy, miscarriage or placental complications. Uterine rupture occurred in 1 in 1000 women who had had a previous caesarean section, which is lower than in other studies. The authors, therefore, concluded that elective caesarean section has a low risk of maternal complications. The study by McAuliffe 22 (nϭ1600) comparing elective caesarean section to planned vaginal delivery replicated these findings and found that the rates of stress and depression were similar.
If we can accept that the overall safety of elective caesarean section is not in question, perhaps subsequent repeat caesarean section, with its known associations with placenta praevia and accreta, should be weighed in the balance. Haemorrhage associated with placenta praevia and accreta can be catastrophic, with serious maternal and neonatal complications. 23 In their review of the Dutch perinatal database, Reitberg et al. 10 showed that 175 caesarean sections would be needed to avoid one fetal death associated with vaginal breech delivery. They assumed that 50% of the women who had had a caesarean section would attempt a vaginal birth after caesarean section (VBAC) and calculated that, for every 12 babies saved by elective caesarean section in the index pregnancy, one would die from uterine scar rupture in a subsequent pregnancy. Voerhoven et al. 24 calculated that the increasing caesarean section rate in the Netherlands had already resulted in 4 potentially avoidable maternal deaths, that in the future a further 9 perinatal deaths will occur as a result of uterine scar rupture and that 140 women will experience life threatening complications related to the initial uterine surgery.
Coughlan et al. 25 reported that in a retrospective cohort of 194 women who had undergone elective caesarean section for breech presentation, one in 10 had a chance of having a repeat section in the next pregnancy but of those who were suitable for a VBAC, 84% were successful. The success rate of VBAC was greater in those women who had had a previous breech presentation than in women who had had a caesarean section with a cephalic presentation in their first pregnancy.
Perhaps the obstetric community needs to wait for the longer term follow-up of women and their babies enrolled in the Term Breech Trial and observe the 'downstream'effects on whole populations of the wholesale movement to planned caesarean section for this indication before this issue can be regarded as settled. The excellent birth registry data from Sweden, Denmark and the Netherlands may yet demonstrate the significant increase in placenta praevia and accreta and the consequently raised perinatal and maternal mortality and morbidity that it is claimed will ensue.
Another implication of an 'elective caesarean for all' policy is the negative impact on training, further reducing the number of practitioners with the skills and experience necessary to deliver a breech vaginally, safely. Even with such a policy, however, undiagnosed breeches will still occur, some women will choose a vaginal birth and even some of those with a caesarean date booked will arrive on the labour ward in established labour. Draycott et al. 26 demonstrated that obstetric emergency training can improve neonatal outcome in a cephalic term population, so regular training programmes would need to be introduced, otherwise vaginal breech delivery may become an ancient art. So, with the future of increasing caesareans and VBACs uncertain, can a policy of careful antenatal selection be safe and reliable enough to predict those women most likely to achieve a vaginal birth? The antepartum identification of the large-fordates fetus, as well as the accurate diagnosis of congenital abnormality, remain problematic, even in developed countries. Any practitioner claiming that vaginal breech delivery is safe in carefully selected individuals will have to contend with the fact that there will be a number of incorrectly allocated individuals delivered vaginally because of the limitations of current antepartum surveillance. Although the PREMODA study attributed some of their improved outcomes to the use of antenatal pelvimetry, convincing evidence supporting this as a reliable screening test has not been published.
So what is left for the thoughtful obstetrician, keen to defend the safety of vaginal breech delivery? Only the consideration of the long-term or 'downstream' effects of planned caesarean section.Although we know that short-term maternal mortality and morbidity is not increased by a policy of planned caesarean section for breech presentation at term, we can now speculate about the long-term effects of repeated caesarean section or the effects of VBAC on maternal health and on other neonates born after the index pregnancy. It is possible that obstetricians need to synthesise these data thoughtfully to produce advice more tailored to a women's individual circumstances. The woman who is only planning one or two births may opt for one or two caesarean sections, if that is her wish, with reasonable confidence that this will be acceptably safe for her and her index pregnancy, as well as the pregnancy that follows. If, on the other hand, the woman and her partner wish to have more than two children, the threshold for advising caesarean section in the index pregnancy or VBAC in subsequent pregnancies would change.
Finally, pregnancy, labour and delivery remain not just medical matters but matters of great cultural and psychological significance; it is inevitable, and even desirable, that this be taken into account. It is also likely that the psychological and cultural feelings of the obstetric community come into play when this question is considered; this has led to the unexpectedly long, slow and hard-fought death of the planned vaginal breech delivery in most developed countries in the world.
